UBS Group
BOUT icon

UBS Group’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

UBS Group’s Portfolio BOUT Stock Details BOUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Buy
330
+98
+42% +$3.85K ﹤0.01% 8232
2025
Q4 		$8.42K Sell
232
-1,096
-83% -$41.1K ﹤0.01% 8362
2025
Q3 		$51.8K Sell
1,328
-444
-25% -$16.7K ﹤0.01% 7538
2025
Q2 		$64.8K Buy
1,772
+1,511
+579% +$52.2K ﹤0.01% 7568
2025
Q1 		$9.47K Buy
261
+105
+67% +$4.09K ﹤0.01% 8688
2024
Q4 		$6.09K Buy
156
+127
+438% +$4.95K ﹤0.01% 8595
2024
Q3 		$1.06K Sell
29
-66
-69% -$2.35K ﹤0.01% 8730
2024
Q2 		$3.31K Buy
+95
New +$3.29K ﹤0.01% 8234
2024
Q1 		– Sell
-346
Closed -$11.4K – 9335
2023
Q4 		$11.4K Sell
346
-30
-8% -$923 ﹤0.01% 7391
2023
Q3 		$11.4K Sell
376
-454
-55% -$14.4K ﹤0.01% 7059
2023
Q2 		$26.8K Buy
830
+712
+603% +$21.7K ﹤0.01% 6754
2023
Q1 		$3.68K Sell
118
-1,129
-91% -$34.4K ﹤0.01% 8291
2022
Q4 		$36.9K Buy
1,247
+84
+7% +$2.52K ﹤0.01% 7037
2022
Q3 		$33K Buy
1,163
+1,116
+2,374% +$34.6K ﹤0.01% 6754
2022
Q2 		$1K Sell
47
-1,232
-96% -$42.3K ﹤0.01% 9822
2022
Q1 		$48K Buy
+1,279
New +$46.8K ﹤0.01% 6532
2021
Q4 		– Sell
-1,583
Closed -$54K – 10265
2021
Q3 		$54K Buy
1,583
+804
+103% +$27.8K ﹤0.01% 6272
2021
Q2 		$26K Sell
779
-1,201
-61% -$40.2K ﹤0.01% 7067
2021
Q1 		$66K Buy
1,980
+1,913
+2,855% +$65.7K ﹤0.01% 6273
2020
Q4 		$2K Sell
67
-886
-93% -$24.2K ﹤0.01% 8081
2020
Q3 		$22K Sell
953
-797
-46% -$18.7K ﹤0.01% 6229
2020
Q2 		$39K Sell
1,750
-167
-9% -$3.46K ﹤0.01% 6079
2020
Q1 		$35K Buy
1,917
+22
+1% +$443 ﹤0.01% 6100
2019
Q4 		$40K Buy
1,895
+507
+37% +$10.1K ﹤0.01% 6474
2019
Q3 		$27K Buy
+1,388
New +$29K ﹤0.01% 6542
2019
Q2 		– Sell
-1,651
Closed -$33K – 7860
2019
Q1 		$33K Buy
+1,651
New +$31.9K ﹤0.01% 5860

Other funds holding BOUT

CWM
Comprehensive Wealth Management Lynnwood, Washington $198M AUM 11.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $135M AUM 29.14% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return

UBS Group's BOUT Position: Q1 2026 in Review

UBS Group increased its CapForce IBD Breakout Opportunities ETF (BOUT) stake by 42% in Q1 2026, buying an estimated $3.85K and bringing the position to 330 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #8232.

UBS Group first reported a position in BOUT in Q1 2019 and has held it in 26 quarters since. The position peaked at $66K in Q1 2021. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • UBS Group held 330 shares of CapForce IBD Breakout Opportunities ETF worth $13K as of Q1 2026.
  • UBS Group bought 98 CapForce IBD Breakout Opportunities ETF shares in Q1 2026, an estimated $3.85K.
  • CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8232 holding.
  • UBS Group first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2019 and has held it in 26 quarters since.
  • UBS Group's CapForce IBD Breakout Opportunities ETF position peaked at $66K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.